BioLineRx (BLRX) Other Non Operating Income (2014)
BioLineRx's (BLRX) quarterly Other Non Operating Income came in at -$1.1 million in Q4 2014, up 45.98% quarter-over-quarter from -$2.0 million in Q3 2014.
BioLineRx (BLRX) Other Non Operating Income (2014) Analysis & Trends
BioLineRx's Other Non Operating Income history runs 1 years deep, the most recent figure standing at -$1.1 million for Q4 2014.
- On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$1.1 million in Q4 2014; TTM through Dec 2014 was -$2.8 million, a N/A change from a year earlier, with the FY2014 full-year figure at -$2.8 million, down 358.34% from the prior year.
- Other Non Operating Income grew to -$1.1 million in Q4 2014 per BLRX's latest filing, from -$2.0 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $424000.0 in Q2 2014 and bottomed at -$2.0 million in Q3 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BioLineRx | 7.05 Bn | 7.06 Bn | 154,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -1.10 Mn |
| Sep 30, 2014 | -2.03 Mn |
| Jun 30, 2014 | 424,000.00 |
| Mar 31, 2014 | -136,000.00 |